Eight LinkedIn Learning courses to build AI skills in 2026, from generative AI and ethics to agents, productivity, ...

Welcome to learn the Research Data Management basics and best practices at a lecture aimed at University of Helsinki researchers and students. The lectures will go through the following topics: what ...

Structure Therapeutics’ stock soared toward an 18-month high in early Monday trading, after mid-stage data for its oral daily GLP-1 receptor appeared comparable to that of one of Eli Lilly’s ...

Structure Therapeutics is developing a daily GLP-1 receptor pill called aleniglipron. Structure Therapeutics' stock soared toward an 18-month high in early Monday trading, after mid-stage data for its ...

This course offers a survey of the major myths of Classical Greece and Rome known to us from ancient texts and art (both ancient and modern) with an examination of their interpretation, influence, and ...

Nov. 3 lecture features NC State's Dr. Julie Swann on Data, Decisions and the Drive to Optimize Health Systems The University of Delaware’s Alfred Lerner College of Business and Economics welcomes ...

AMES, Iowa — Research suggests the average adult makes about 35,000 decisions each day. Most of those choices are routine and barely noticed — choosing what to eat for breakfast, for instance, won’t ...

In his 1960 book Theory and Design in the First Machine Age, the critic and historian Reyner Banham presciently noted a growing chasm between technological change and the capacity of designers to ...

NEW YORK--(BUSINESS WIRE)--KBRA releases research examining the differences between asset-backed securities (ABS) and commercial mortgage-backed securities (CMBS) for data center transactions, ...

Continuing a little-known but rich history of big bands that formed on reservations during the early 20th century, the Julia Keefe Indigenous Big Band brings charisma, passionand purpose to every ...

Structure Therapeutics' stock has declined over 40% since last year, but its differentiated technology platform and promising drug pipeline still support a "Buy" rating. Structure's lead candidate, ...